Nemaura Commences Pilot Program of Miboko with the NHS in the United Kingdom
29 nov. 2022 08h00 HE
|
Nemaura Medical, Inc
LOUGHBOROUGH, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD)(“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing non-invasive...
GLUCOTRACK ANNOUNCES THE HIRING OF DR. MARK TAPSAK
14 oct. 2022 09h45 HE
|
GlucoTrack, Inc.
INDUSTRY VETERAN TO LEAD NEW CONTINUOUS GLUCOSE MONITORING R&D PROGRAM Rutherford, NJ, Oct. 14, 2022 (GLOBE NEWSWIRE) -- GlucoTrack, Inc. (Nasdaq: GCTK) (“GlucoTrack” or the “Company”), a...
GLUCOTRACK ANNOUNCES THE HIRING OF DR. MARK TAPSAK
14 oct. 2022 09h30 HE
|
GlucoTrack, Inc.
INDUSTRY VETERAN TO LEAD NEW CONTINUOUS GLUCOSE MONITORING R&D PROGRAM Rutherford, NJ, Oct. 14, 2022 (GLOBE NEWSWIRE) -- GlucoTrack, Inc. (Nasdaq: GCTK) (“GlucoTrack” or the “Company”), a...
Nemaura Receives Provisional Purchase Order from Middle East Licensee TPMENA
12 oct. 2022 11h00 HE
|
Nemaura Medical, Inc
LOUGHBOROUGH, ENGLAND, Oct. 12, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and...
Nemaura Medical Reports Fiscal First Quarter 2023 Results and Provides Business Update
15 août 2022 08h30 HE
|
Nemaura Medical, Inc
Loughborough, England, Aug. 15, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing a...
Nemaura Medical Reports Financial Results and Provides Business Update for the Fiscal Year Ended March 31, 2022
30 juin 2022 08h00 HE
|
Nemaura Medical, Inc
Loughborough, England, June 30, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing a...
Nemaura Medical Strengthens Balance Sheet with Further Non-Dilutive Funding
23 mai 2022 06h30 HE
|
Nemaura Medical, Inc
Loughborough, England, May 23, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD), a medical technology company focused on commercializing a daily disposable wearable glucose sensor and...
Happy Bob Integrates With Dexcom CGM to Provide a Playful Way to Engage With Real-Time Glucose Values and Improve Overall Self-Care
08 mars 2022 07h00 HE
|
Harald AI
HELSINKI, March 08, 2022 (GLOBE NEWSWIRE) -- Diabetes tech startup Harald AI today introduced a more expansive way for Dexcom Continuous Glucose Monitoring (CGM) System users to engage with their...
Global Continuous Glucose Monitoring Devices (CGM) Market to Hit USD 13.24 Billion by 2028; Continuous Glucose Monitoring Devices Industry CAGR of 10.8% between 2022-2028; Exclusive Insight Report by Vantage Market Research
08 mars 2022 03h12 HE
|
Vantage Market Research
WASHINGTON, March 08, 2022 (GLOBE NEWSWIRE) -- Vantage Market Research’s recent analysis of the Global Continuous Glucose Monitoring Devices Market finds that rising incidence of diabetes is...
Nemaura Medical Announces Fiscal Second Quarter 2022 Financial Results and Provides Business Update
15 nov. 2021 09h30 HE
|
Nemaura Medical, Inc
Loughborough, England, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...